The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines

Guan Xiuwen; Wang Haijuan; Ma Fei; Qian Haili; Yi Zongbi; Xu Binghe

首页> 外文期刊>Medicine. >The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines

【24h】

The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines

机译：程序性细胞死亡1和程序性细胞死亡1配体抑制剂对晚期黑色素瘤的疗效和安全性遵循PRISMA指南进行临床试验的荟萃分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The purpose of this study was to investigate the efficacy and safety of programmed cell death 1 (PD-1) and programmed cell death 1 ligand (PD-L1) inhibitors using a meta-analysis of present trials for advanced melanoma.

机译：这项研究的目的是使用对晚期黑素瘤的现有试验的荟萃分析，研究程序性细胞死亡1（PD-1）和程序性细胞死亡1配体（PD-L1）抑制剂的疗效和安全性。

著录项

来源
《Medicine.》 |2016年第11期|共9页
作者
Guan Xiuwen; Wang Haijuan; Ma Fei; Qian Haili; Yi Zongbi; Xu Binghe;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines [J] . Guan Xiuwen, Wang Haijuan, Ma Fei, Medicine. . 2016,第11期

机译：程序性细胞死亡1和程序性细胞死亡1配体抑制剂对晚期黑色素瘤的疗效和安全性遵循PRISMA指南进行临床试验的荟萃分析
2. Efficacy and safety of programmed cell death-1/programmed cell death ligand-1 inhibitors in advanced urothelial malignancy: A systematic review and meta-analysis [J] . Smita Pattanaik, Sumit Dey, Nishant Jaiswal, Indian Journal of Urology: IJU: Journal of the Urological Society of India . 2019,第2期

机译：程序性细胞死亡-1 /程序性细胞死亡配体-1抑制剂在晚期尿路上皮恶性肿瘤中的疗效和安全性：系统评价和荟萃分析
3. Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis [J] . Xiaoying Sun, Raheleh Roudi, Ting Dai, BMC Cancer . 2019,第1期

机译：免疫相关的不良事件与编程的细胞死亡蛋白-1和编程的细胞死亡配体1用于非小细胞肺癌的抑制剂：PRISMA系统审查和META分析
4. The high expression level of programmed death-1 ligand 2 in oral lichen planus and the possible costimulatory effect on human T cells [C] . Guan-Huan Du, Xiao-Peng Qin, Qin Li, Academic Committee conference of Shanghai key lab of stomatology . 2011

机译：口腔扁平苔藓中程序性死亡1配体2的高表达水平及其对人T细胞的共刺激作用
5. Characterization of feline programmed cell death 1 and programmed cell death ligand 1 [D] . Folkl, Alex 2008

机译：猫的程序性细胞死亡1和程序性细胞死亡配体1的表征
6. The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma [O] . Xiuwen Guan, Haijuan Wang, Fei Ma, -1

机译：程序性细胞死亡1和程序性细胞死亡1配体抑制剂对晚期黑素瘤的功效和安全性
7. The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma [O] . Xiuwen Guan, Haijuan Wang, Fei Ma, 2016

机译：编程细胞死亡1和编程细胞死亡1配体抑制剂的先进黑素瘤的疗效和安全性

The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines

摘要

著录项

相似文献

相关主题

期刊订阅